NVIDIA's AI Agents Are Already Running 90% of ServiceNow Tickets — And This Is Just the Start

90%
ServiceNow L1 Tickets Automated
50% in the US
Doctors Using AI Clinical Platforms
10x potential increase
AI Impact on Knowledge Worker Output

A new 31-minute analysis reveals how NVIDIA's AI ecosystem is quietly automating the enterprise and pioneering a trillion-dollar shift in software and healthcare. The report uncovers that ServiceNow's CEO confirms 90% of Level 1 service tickets are now handled by autonomous AI agents, not just chatbots, performing complex backend tasks. This is powered by NVIDIA's open-source toolkit, where projects like OpenClaw are gaining GitHub traction faster than Linux or React, signaling explosive developer adoption. The analysis also details a groundbreaking partnership with pharmaceutical giant Eli Lilly, which is using NVIDIA's platform to democratize its internal, multi-billion dollar data for AI-driven drug discovery. Furthermore, the video explores how AI is creating 'super-engineers' and transforming SaaS business models from selling user seats to selling 'agents as a service.' The full report breaks down the specific companies, platforms, and investment implications of this accelerating AI agent revolution...

📈

The AI agent revolution is moving from hype to reality. NVIDIA's open ecosystem, featuring tools like the Agent Toolkit and OpenShell, is enabling autonomous agents that manage calendars, detect home leaks, and now handle 90% of ServiceNow's basic service tickets. This shift is redefining SaaS, moving from selling user seats to selling 'agents as a service.'

💡

The implications extend far beyond software. In healthcare, NVIDIA is partnering with Roche and Eli Lilly to accelerate drug discovery and build AI-driven healthcare companies. Tools like Open Evidence are already used by 50% of US doctors, enhancing clinical decision-making. The analysis suggests knowledge workers could see a 10x efficiency boost, creating 'super-engineers' rather than causing mass displacement.

⚠️

While the opportunities are vast, the report highlights critical challenges. Security remains paramount for enterprise adoption, with principles like 'default deny' permissions being essential for sensitive operations. The rapid community adoption of projects like OpenClaw also presents both an acceleration vector and a potential governance risk as capabilities expand.

Subscribe to FlowCo Pro for full analysis reports and precise price targets.

View Full Analysis

Loading report...